A major discovery in cancer investigation is arising with the use of mini-antibodies to re-engage damaged p53. This vital malignant protector protein is frequently disabled in many forms of malignancies, causing https://social40.com/story7535673/mini-antibodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-cancer-management